Approval · Notice of Compliance 28530 · 2022
SUBLOCADE: Notice of Compliance 28530
Issued July 5, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28530
- Date
- July 5, 2022
- Company
- Indivior Uk LimitedHull, --, United Kingdom
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety Updates to the Product Monograph (PM)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUBLOCADE | Not yet assigned | — |
Medicinal ingredients
- BUPRENORPHINE 100 MG per 0.5ML
- BUPRENORPHINE 300 MG per 1.5ML